The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 CuraGen Corp.  (CRGN) Trade Now »     Rate CRGN  -  Discuss CRGN  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
This is a micro-cap stock and may be a target of manipulation. Always do your research!

SocialPicks Sentiment:

** v.s. other stocks
This Quarter's Sentiment:
All:
58.0%
Top:
100.0%
Rate CRGN:



CRGN Analysis & Videos »


CRGN: Bull or Bear?

FDA, Clinical Trial Calendars: Cancer Drug Updates from ASCO Graphic_rating_buy CRGN
Mikerun
73%
By  Mike Havrilla   (+1.04%  risk: conservative)  05/31/09 Comment


Clinical Trial Updates: Cancer Drugs in Focus as ASCO Approaches Graphic_rating_buy CRGN
Mikerun
73%
By  Mike Havrilla   (+1.04%  risk: conservative)  05/17/09 Comment





People Bullish on CRGN

gsmartin72
Analyst
N/A
2 mos ago

Mikerun
Mike Havrilla
Principal
73%
5 mos ago

eddytauber
Analyst
12%
about 1 year ago

Bullet_for_my_valentine
athf
Sr. Analyst
 7 %
over 2 years ago


People Bearish on CRGN

jeffchai
Analyst
N/A
about 1 mo ago

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.37% 379
2 18.14 +70.70% 209
3 17.66 +25.67% 55
4 13.47 +14.32% 61
5 12.13 +78.05% 39


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on CRGN


Discussion Wall + Add  

amritadas   (+0.00%)
A FREE report on the approval of a new Gout Drug An upcoming treatment by a small cap company for Gout to face FDA decision on approval shortly. Gout has traditionally been a difficult disease to tre
+   0 replies

amritadas   (+0.00%)
a
+   0 replies

amritadas   (+0.00%)
A FREE report on the approval of a new Gout Drug An upcoming treatment by a small cap company for Gout to face FDA decision on approval shortly. Gout has traditionally been a difficult disease to tre
+   0 replies

amritadas   (+0.00%)
Free report on upcoming FDA panel decision of Corvu.. FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by th...
+   0 replies


More Resources

Graphic_arrow1 About CuraGen Corp. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch